United States - English - NLM (National Library of Medicine)

proficient rx lp - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 40 mg in 1 ml - cromolyn sodium ophthalmic solution is indicated in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis. cromolyn sodium ophthalmic solution is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium or to any of the other ingredients.

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 40 mg in 1 ml - cromolyn sodium ophthalmic solution is indicated in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis. cromolyn sodium ophthalmic solution is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium or to any of the other ingredients.

United States - English - NLM (National Library of Medicine)

micro labs limited - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 100 mg in 5 ml - cromolyn sodium oral solution (concentrate) 100 mg/5 ml is indicated in the management of patients with mastocytosis. use of this product has been associated with improvement in diarrhea, flushing, headaches, vomiting, urticaria, abdominal pain, nausea, and itching in some patients. cromolyn sodium oral solution (concentrate) 100 mg/5 ml is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium.

United States - English - NLM (National Library of Medicine)

akorn - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 40 mg in 1 ml - cromolyn sodium ophthalmic solution is indicated in the treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal keratitis. cromolyn sodium ophthalmic solution is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium or to any of the other ingredients.

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 20 mg in 2 ml - cromolyn sodium inhalation solution usp is a prophylactic agent indicated in the management of patients with bronchial asthma. in patients whose symptoms are sufficiently frequent to require a continuous program of medication, cromolyn sodium inhalation solution usp is given by inhalation on a regular daily basis (see dosage and administration ). the effect of cromolyn sodium is usually evident after several weeks of treatment, although some patients show an almost immediate response. in patients who develop acute bronchoconstriction in response to exposure to exercise, toluene diisocyanate, environmental pollutants, etc., cromolyn sodium should be given shortly before exposure to the precipitating factor (see dosage and administration ). cromolyn sodium inhalation solution is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium.

United States - English - NLM (National Library of Medicine)

woodward pharma services llc - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 20 mg in 2 ml - cromolyn sodium inhalation solution usp is a prophylactic agent indicated in the management of patients with bronchial asthma. in patients whose symptoms are sufficiently frequent to require a continuous program of medication, cromolyn sodium inhalation solution usp is given by inhalation on a regular daily basis (see dosage and administration ). the effect of cromolyn sodium is usually evident after several weeks of treatment, although some patients show an almost immediate response. in patients who develop acute bronchoconstriction in response to exposure to exercise, toluene diisocyanate, environmental pollutants, etc., cromolyn sodium should be given shortly before exposure to the precipitating factor (see dosage and administration ). cromolyn sodium inhalation solution is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium.

United States - English - NLM (National Library of Medicine)

wallace pharmaceuticals inc. - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 20 mg in 1 ml - cromolyn sodium, usp is indicated in the management of patients with mastocytosis. use of this product has been associated with improvement in diarrhea, flushing, headaches, vomiting, urticaria, abdominal pain, nausea, and itching in some patients. cromolyn sodium, usp is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium.

United States - English - NLM (National Library of Medicine)

rising pharma holdings, inc. - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 100 mg in 5 ml - cromolyn sodium oral solution, concentrate is indicated in the management of patients with mastocytosis. use of this product has been associated with improvement in diarrhea, flushing, headaches, vomiting, urticaria, abdominal pain, nausea, and itching in some patients. cromolyn sodium oral solution, concentrate is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium.

United States - English - NLM (National Library of Medicine)

woodward pharma services llc - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium 100 mg in 5 ml - cromolyn sodium oral solution (concentrate) is indicated in the management of patients with mastocytosis. use of this product has been associated with improvement in diarrhea, flushing, headaches, vomiting, urticaria, abdominal pain, nausea, and itching in some patients. cromolyn sodium oral solution (concentrate) is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium.

United States - English - NLM (National Library of Medicine)

micro labs limited - cromolyn sodium (unii: q2wxr1i0pk) (cromolyn - unii:y0tk0fs77w) - cromolyn sodium inhalation solution, usp is a prophylactic agent indicated in the management of patients with bronchial asthma. in patients whose symptoms are sufficiently frequent to require a continuous program of medication, cromolyn sodium inhalation solution, usp is given by inhalation on a regular daily basis (see dosage and administration). the effect of cromolyn sodium inhalation solution is usually evident after several weeks of treatment, although some patients show an almost immediate response. in patients who develop acute bronchoconstriction in response to exposure to exercise, toluene diisocyanate, environmental pollutants, etc., cromolyn sodium inhalation solution should be given shortly before exposure to the precipitating factor (see dosage and administration). cromolyn sodium inhalation solution is contraindicated in those patients who have shown hypersensitivity to cromolyn sodium. cromolyn sodium inhalation solution usp an aqueous solution for nebulization not for